501 - 525 of 60.877
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 275,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,69x
- Analysis
- Novo Nordisk Call 385,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,28x
- Analysis
- Novo Nordisk Call 465,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,59x
- Analysis
- Robinhood Put 150,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 1,42x
- Analysis
- Novo Nordisk Call 395,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,69x
- Analysis
- Hims & Hers Health Put 30,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,70x
- Analysis
- Novo Nordisk Call 355,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,31x
- Analysis
- Novo Nordisk Call 455,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,69x
- Analysis
- Novo Nordisk Call 325,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,62x
- Analysis
- Novo Nordisk Call 325,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,12x
- Analysis
- Novo Nordisk Call 475,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,20x
- Analysis
- Novo Nordisk Call 365,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,08x
- Analysis
- Novo Nordisk Call 375,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,14x
- Analysis
- Novo Nordisk Call 355,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,97x
- Analysis
- Novo Nordisk Call 435,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,12x
- Analysis
- Novo Nordisk Call 425,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,89x
- Analysis
- Novo Nordisk Call 445,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,49x
- Analysis
- Novo Nordisk Call 495,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,36x
- Analysis
- Novo Nordisk Call 345,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,25x
- Analysis
- Novo Nordisk Call 335,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,75x
- Analysis
- Novo Nordisk Call 395,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,31x
- Analysis
- Novo Nordisk Call 405,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,30x
- Analysis
- Novo Nordisk Call 435,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,46x
- Analysis
- Novo Nordisk Call 285,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,18x
- Analysis
- Novo Nordisk Call 265,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,93x
- Analysis